A Phase 1/2, Open-Label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination with MEDI4736 and MEDI0680 Monotherapy in Subjects with Select Advanced Malignancies
- Kwan, Edmond (Primary Chief Investigator (PCI))
Project: Other